ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1843

Single Cell Expression Quantitative Trait Loci (eQTL) Analysis of Established SLE-Risk Loci in Lupus Patient Monocytes

Yogita Ghodke-Puranik1, Zhongbo Jin1, Wei Fan2, Mark A. Jensen3, Jessica M. Dorschner1, Danielle Vsetecka1, Shreyasee Amin4, Ashima Makol4, Floranne C. Ernste5, Thomas Osborn4, Kevin Moder4, Vaidehi Chowdhary4 and Timothy B. Niewold6, 1Division of Rheumatology and Department of Immunology, Mayo Clinic, Rochester, MN, 2Department of Rheumatology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, China, Shanghai, China, 3Department of Immunology and Division of Rheumatology, Mayo Clinic, Rochester, MN, 4Rheumatology, Mayo Clinic, Rochester, MN, 5Division of Rheumatology, Mayo Clinic, Rochester, MN, 6Rheumatology and Immunology, Mayo Clinic, Rochester, MN

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: autoimmune diseases and interferons, Gene Expression, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Systemic Lupus Erythematosus – Human Etiology and Pathogenesis - Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  While most of the confirmed SLE-risk loci are in or near genes with immune system function, a major unanswered question is how these loci influence diverse immune cell subsets. In this study we performed a single cell eQTL analysis in human monocytes to determine impact of some well-established SLE-risk loci in single human monocytes.

Methods:  CD14++CD16- classical monocytes (CL) and CD14dimCD16+ non classical (NCL) monocytes from SLE patients were purified by magnetic separation. The Fluidigm C1 System was used for single cell capture and target gene pre-amplification and equal numbers of classical and non-classical monocytes were studied. Real time PCR was used to quantify expression of 90 monocyte-related genes, and the same SLE patients were genotyped for 7 SLE-risk SNPs to enable eQTL analysis. Non-parametric analyses were used with the single cell data in CL and NCL populations separately.

Results:

We observed a large number of significant eQTL associations that surpassed the 5% FDR, supporting the idea that single cell gene expression data allows for robust eQTL discovery. The SLE-associated SNPs demonstrated more eQTLs in NCLs as compared to CLs (p=2.5×10-8). For a given SNP, the eQTL associated transcripts differed between cell types (p<0.001 for all 7 SNPs for discordance), suggesting that the same SNP resulted in different cellular events between the two monocyte subsets. When comparing eQTL lists between the different SLE-associated SNPs, there was a greater degree of sharing observed in NCLs as compared to CLs. Loci which shared a significant proportion of eQTL associations with each other in NCLs included TNFAIP3, IRF5, IRF7, PTPN22, and SPP1. In CLs, TNFAIP3 shared a large number of eQTLs with SPP1 and ITGAM, although SPP1 and ITGAM showed more limited overlap with each other. Thus, SLE-associated risk loci exert coordinated effects on gene expression within individual human monocytes, and the risk loci interact in different ways in different cell types.

Conclusion:  This study emphasizes the strength of single cell gene expression strategy for eQTL discovery. Our study revealed striking differences in the occurrence and interaction between of SLE risk associated eQTLs within different but closely related cell types. This suggests pleiotropic effects from each locus across various immune cell types, and a high degree of complexity when considering how these loci impact the immune system.


Disclosure: Y. Ghodke-Puranik, None; Z. Jin, None; W. Fan, None; M. A. Jensen, None; J. M. Dorschner, None; D. Vsetecka, None; S. Amin, None; A. Makol, None; F. C. Ernste, None; T. Osborn, None; K. Moder, None; V. Chowdhary, None; T. B. Niewold, None.

To cite this abstract in AMA style:

Ghodke-Puranik Y, Jin Z, Fan W, Jensen MA, Dorschner JM, Vsetecka D, Amin S, Makol A, Ernste FC, Osborn T, Moder K, Chowdhary V, Niewold TB. Single Cell Expression Quantitative Trait Loci (eQTL) Analysis of Established SLE-Risk Loci in Lupus Patient Monocytes [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/single-cell-expression-quantitative-trait-loci-eqtl-analysis-of-established-sle-risk-loci-in-lupus-patient-monocytes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-cell-expression-quantitative-trait-loci-eqtl-analysis-of-established-sle-risk-loci-in-lupus-patient-monocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology